首页|期刊导航|药物分析学报(英文)|Halogenated anthraquinones in breast cancer therapy:Structural modifications targeting VEGF-related angiogenesis pathways

Halogenated anthraquinones in breast cancer therapy:Structural modifications targeting VEGF-related angiogenesis pathwaysOA

Halogenated anthraquinones in breast cancer therapy:Structural modifications targeting VEGF-related angiogenesis pathways

Chenyu Zhou;Murni Nazira Sarian;Xiaohui Tong;Rongchun Han;Theebaa Anasamy;Hamizah Shahirah Hamezah

Institute of Systems Biology(INBIOSIS),Universiti Kebangsaan Malaysia,UKM,Bangi,Selangor,43600,MalaysiaInstitute of Systems Biology(INBIOSIS),Universiti Kebangsaan Malaysia,UKM,Bangi,Selangor,43600,MalaysiaSchool of Life Sciences,Anhui University of Chinese Medicine,Hefei,230012,ChinaSchool of Pharmacy,Anhui University of Chinese Medicine,Hefei,230012,ChinaFaculty of Medicine,Manipal University College Malaysia(MUCM),Jalan Padang Jambu,Bukit Baru,Melaka,75150,MalaysiaInstitute of Systems Biology(INBIOSIS),Universiti Kebangsaan Malaysia,UKM,Bangi,Selangor,43600,Malaysia

Breast cancerAnti-angiogenesisVEGF pathwayStructure-activity relationshipsHalogenated anthraquinones

Breast cancerAnti-angiogenesisVEGF pathwayStructure-activity relationshipsHalogenated anthraquinones

《药物分析学报(英文)》 2026 (6)

1672-1689,18

This work was supported by Universiti Kebangsaan Malaysia under Dana Impak Perdana 2.0 Research Grant to HSH(Grant No.:DIP-2024-021).The Manipal University College Malaysia under MUCM-MRB Joint Seed Grant to TA(Grant No.:MUCM-MRB/002/2024)also supported this work.Figs.1-4 and the graphical ab-stract were created by using BioRender.com under a publication license.

10.1016/j.jpha.2025.101538

评论